verapamil has been researched along with pf-3450074 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, MC; Do, HT; Du, H; Hachiya, A; Kirby, KA; Sahani, RL; Sarafianos, SG; Tedbury, PR; Vernekar, SKV; Wang, L; Wang, Z; Xie, J; Zhang, H | 1 |
| Akther, T; Castaner, AE; Cilento, ME; Kirby, KA; Sahani, RL; Sarafianos, SG; Wang, Z; Xie, J; Zhang, H | 1 |
2 other study(ies) available for verapamil and pf-3450074
| Article | Year |
|---|---|
Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
Topics: Animals; Anti-HIV Agents; Capsid Proteins; Cell Line; Dose-Response Relationship, Drug; HIV-1; Humans; Indoles; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Virus Replication | 2020 |
Potency and metabolic stability: a molecular hybrid case in the design of novel PF74-like small molecules targeting HIV-1 capsid protein.
Topics: | 2021 |